Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia Nov 22, 2021 10:40 HKT | |
|
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership Nov 12, 2021 07:30 HKT | |
|
Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies - OCT Webinar Oct 19, 2021 15:00 HKT | |
|
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain Oct 19, 2021 15:00 HKT | |
|
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox Oct 14, 2021 14:45 HKT | |
|
Edison Oncology and Apollomics Announce Treatment of First Patient by EO1001 (APL-122) in a Phase I/IIa Clinical Trial Oct 01, 2021 10:00 HKT | |
|
Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research Sep 24, 2021 09:00 HKT | |
|
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices Sep 21, 2021 12:00 HKT | |
|
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices Sep 21, 2021 12:00 HKT | |
|
Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain Sep 07, 2021 12:20 HKT | |
|
Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia Aug 26, 2021 13:00 HKT | |
|
Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership Aug 10, 2021 14:00 HKT | |
|
Apollomics, Inc. Doses First Patient in a Phase I Clinical Trial of APL-102 Aug 10, 2021 11:53 HKT | |
|
ClinTex (CTi) Launches CTi-OEM Blockchain Clinical Trial App Aug 03, 2021 18:00 HKT | |
|
Singapore cord blood bank Cryoviva establishes footprint in the UAE Jul 27, 2021 08:00 HKT | |
|
Premier of South Australia Launches $1.5m Vaccine and Immunobiology State-of-the art Laboratory for APAC Clinical Trials Jul 14, 2021 17:00 HKT | |
|
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia Jul 09, 2021 20:00 HKT | |
|
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth Jun 28, 2021 14:00 HKT | |
|
Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities Jun 04, 2021 08:00 HKT | |
|
Agilex Biolabs and Gyros Protein Technologies Partner for BioAnalysis Zone Webinar on Singlicate Analysis May 31, 2021 13:00 HKT | |
|